However, given the low prevalence of WRN mutations in tRCC (both human and murine), whether it is implicated in tRCC pathogenesis remains to be determined. This evidence concerns the gene WRN and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.